Using Machine Learning to Explore the Impact of Borderline Hyponatremia on Adverse Outcomes in Heart Failure Patients: A Data Mining Approach

Xiaolei Wan

doi:10.62051/ijcsit.v3n2.25

Authors

Xiaolei Wan

DOI:

https://doi.org/10.62051/ijcsit.v3n2.25

Keywords:

Hyponatremia, Heart failure, Threshold, Machine learning

Abstract

An association between slightly low serum sodium levels within the normal range and increased mortality risk in heart failure patients has been observed. However, the precise borderline level of serum sodium in heart failure patients remains undetermined, and the impact of borderline hyponatremia on heart failure outcomes remains unclear. This study aims to identify the threshold for borderline hyponatremia and assess the relationship between borderline hyponatremia and adverse outcomes in hospitalized heart failure patients. The adverse events, encompassing all-cause deaths and cardiac transplantation. This retrospective cohort study included 1,249 heart failure patients treated at the Heart Failure Center of Fuwai Hospital, Beijing, China, between 2009 and 2013, of which the incidence of adverse events was 23.1%. The optimal threshold for borderline hyponatremia were identified using Youden index and machine learning. Furthermore, we used Cox proportional risk analysis, smooth curve fitting, and Kaplan-Meier survival curve to assess the relationship between sodium levels and the incidence of adverse outcomes in patients with heart failure while considering potential confounding factors such as age and gender. We created three different models using univariate and multivariate Cox proportional-hazard regression models, including an unadjusted model, a minimally adjusted model, and a fully adjusted model. For patients with borderline hyponatremia, the HRs and 95%CIs for their unadjusted, minimally adjusted, and fully adjusted models were 1.90 (1.46, 2.48), P=<0.0001, 1.86 (1.43, 2.44), P<0.0001, and 1.37 (1.03, 1.81), P=0.0280. There was a significant association between borderline hyponatremia and adverse outcome.

Downloads

Download data is not yet available.

References

A. P. Ambrosy et al., “The global health and economic burden of hospitalizations for heart failure: Lessons learned from hospitalized heart failure registries,” J Am Coll Cardiol, vol. 63, no. 12, pp. 1123–1133, 2014, doi: 10.1016/j.jacc.2013.11.053.

N. Farré et al., “Medical resource use and expenditure in patients with chronic heart failure: a population-based analysis of 88 195 patients,” Eur J Heart Fail, vol. 18, no. 9, pp. 1132–1140, 2016, doi: 10.1002/ejhf.549.

A. M. Chamberlain et al., “Burden and Timing of Hospitalizations in Heart Failure: A Community Study,” Mayo Clin Proc, vol. 92, no. 2, p. 184, Feb. 2017, doi: 10.1016/J.MAYOCP.2016.11.009.

P. A. Heidenreich et al., “Forecasting the Impact of Heart Failure in the United States A Policy Statement From the American Heart Association,” pp. 606–619, 2013, doi: 10.1161/HHF.0b013e318291329a.

H. J. Adrogué, B. M. Tucker, and N. E. Madias, “Diagnosis and Management of Hyponatremia: A Review,” JAMA, vol. 328, no. 3, pp. 280–291, Jul. 2022, doi: 10.1001/JAMA.2022.11176.

M. Darmon et al., “Prognostic consequences of borderline dysnatremia: pay attention to minimal serum sodium change,” Crit Care, vol. 17, no. 1, Jan. 2013, doi: 10.1186/CC11937.

M. Gheorghiade et al., “Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry,” Eur Heart J, vol. 28, no. 8, pp. 980–988, Apr. 2007, doi: 10.1093/EURHEARTJ/EHL542.

L. Balling, M. Schou, L. Videbæk, P. Hildebrandt, H. Wiggers, and F. Gustafsson, “Prevalence and prognostic significance of hyponatraemia in outpatients with chronic heart failure,” Eur J Heart Fail, vol. 13, no. 9, pp. 968–973, Sep. 2011, doi: 10.1093/EURJHF/HFR086.

Y. Girardeau, A. S. Jannot, G. Chatellier, and O. Saint-Jean, “Association between borderline dysnatremia and mortality insight into a new data mining approach,” BMC Med Inform Decis Mak, vol. 17, no. 1, pp. 1–10, 2017, doi: 10.1186/s12911-017-0549-7.

S. Peng, J. Peng, L. Yang, and W. Ke, “Relationship between serum sodium levels and all-cause mortality in congestive heart failure patients: A retrospective cohort study based on the Mimic-III database,” Front Cardiovasc Med, vol. 9, Jan. 2023, doi: 10.3389/FCVM.2022.1082845.

N. Deubner et al., “Dysnatraemia in heart failure,” Eur J Heart Fail, vol. 14, no. 10, pp. 1147–1154, Oct. 2012, doi: 10.1093/EURJHF/HFS115.

D. Rusinaru et al., “Relationship of serum sodium concentration to mortality in a wide spectrum of heart failure patients with preserved and with reduced ejection fraction: an individual patient data meta-analysis(†): Meta-Analysis Global Group in Chronic heart failure (MAGGIC),” Eur J Heart Fail, vol. 14, no. 10, pp. 1139–1146, Oct. 2012, doi: 10.1093/EURJHF/HFS099.